XTX Topco Ltd acquired a new position in Transcat, Inc. (NASDAQ:TRNS - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,085 shares of the scientific and technical instruments company's stock, valued at approximately $326,000.
A number of other institutional investors have also recently bought and sold shares of the business. Barclays PLC boosted its holdings in shares of Transcat by 393.0% in the 3rd quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company's stock worth $1,826,000 after buying an additional 12,061 shares during the last quarter. Geode Capital Management LLC boosted its stake in Transcat by 5.4% in the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company's stock valued at $26,269,000 after acquiring an additional 11,106 shares during the last quarter. Virtu Financial LLC grew its position in shares of Transcat by 127.0% during the 3rd quarter. Virtu Financial LLC now owns 4,136 shares of the scientific and technical instruments company's stock valued at $499,000 after acquiring an additional 2,314 shares during the period. Principal Financial Group Inc. increased its stake in shares of Transcat by 8.8% during the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company's stock worth $557,000 after purchasing an additional 373 shares during the last quarter. Finally, Diversified Trust Co raised its holdings in shares of Transcat by 53.6% in the 4th quarter. Diversified Trust Co now owns 6,120 shares of the scientific and technical instruments company's stock worth $647,000 after purchasing an additional 2,135 shares during the period. Institutional investors own 98.34% of the company's stock.
Insiders Place Their Bets
In other Transcat news, Director Craig D. Cairns purchased 1,200 shares of the firm's stock in a transaction that occurred on Friday, January 31st. The stock was bought at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the purchase, the director now directly owns 1,910 shares in the company, valued at $147,108.20. The trade was a 169.01 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.30% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Several analysts have issued reports on TRNS shares. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. StockNews.com lowered Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. HC Wainwright lowered their price target on Transcat from $126.00 to $106.00 and set a "buy" rating on the stock in a research report on Wednesday, January 29th. Finally, Northland Securities reissued a "market perform" rating and set a $85.00 price objective (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Transcat currently has a consensus rating of "Hold" and a consensus price target of $111.50.
View Our Latest Research Report on Transcat
Transcat Trading Down 5.2 %
NASDAQ:TRNS traded down $4.43 during midday trading on Monday, reaching $80.70. 43,034 shares of the stock traded hands, compared to its average volume of 74,084. The stock has a market capitalization of $751.24 million, a P/E ratio of 43.62 and a beta of 0.67. Transcat, Inc. has a 12 month low of $67.56 and a 12 month high of $147.12. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The company has a fifty day moving average of $77.14 and a 200 day moving average of $94.21.
Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same period last year, the business earned $0.56 earnings per share. On average, research analysts predict that Transcat, Inc. will post 2.3 EPS for the current year.
Transcat Profile
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Articles
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
